2Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagno- sis and treatment of pulmonary hypertension: the Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS) , endorsed by the International Society of Heart and Lung Transplantation (ISHLT). Eur Heart J, 2009, 30:2493-2537.
3Giglia TM, Humpl T. Preoperative pulmonary hemodynamics and as- sessment of operability: is there a pulmonary vascular resistance that precludes cardiac operation?. Pediatr Crit Care Med, 2010,11 (2 Suppl) :S57-S69.
4Viswanathan S, Kumar RK. Assessment of operability of congenital cardiac shunts with increased pulmonary vascular resistance. Catheter Cardiovasc Interv, 2008, 71:665-670.
6Chin KM, Kim NH, Rubin LJ. The right ventricle in pulmonary hy- pertension. Coron Artery Dis, 2005,16 : 13-18.
7Howard LS. Prognostic factors in pulmonary arterial hypertension : assessing the course of the disease. Eur Respir Rev, 2011, 20: 236-242.
8Drake JI, Bogaard H J, Mizuno S, et al. Molecular signature of a right heart failure program in chronic advanced pulmonary hyperten- sion. Am J Respir Cell Mol Biol, 2011, 45:1239-1247.
9Galie N, Hoeper MM, Humbert M, et al. Guidelines for the diagnosis and treatment of pulmonary hyperten- sion: The Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS), endorsed by the International Society of Heart and Lung Transplantation (ISHLT)[J]. Eur Heart J, 2009, 30:2 493-2 537.
10Giglia TM, Humpl T. Preoperative pulmonary hemodynamics and assessment of operability., is there a pul- monary vascular resistance that precludes cardiac operation[J]? Pediatr Crit Care Med, 2010, 11(Suppl):57-69.
